UCLA Journal of Radiation Oncology SPRING 2024 - Flipbook - Page 44
UCLA RADIATION ONCOLOGY JOURNAL
61. OJ Gurney-Champion, G Landry, KR Redalen, et al. Potential of deep learning in quantitative magnetic
resonance imaging for personalized radiotherapy. Semin Radiat Oncol, 32 (4) (2022), pp. 377-388, 10.1016/j.
semradonc.2022.06.007
62. J Ng, F Gregucci, RT Pennell, et al. MRI-LINAC: A transformative technology in radiation oncology. Front
Oncol, 13 (2023), Article 1117874, 10.3389/fonc.2023.1117874
63. T Finazzi, MA Palacios, CJA Haasbeek, et al. Stereotactic MR-guided adaptive radiation therapy for peripheral
lung tumors. Radiother. Oncol., 144 (2020), pp. 46-52, 10.1016/j.radonc.2019.10.013
64. AM Chen, M Cao, S Hsu, et al. Magnetic resonance imaging guided reirradiation of recurrent and second
primary head and neck cancer. Adv Radiat Oncol, 2 (2) (2017), pp. 167-175, 10.1016/j.adro.2017.02.002
65. S Lee, P Yadav, AJ van der Kogel, et al. In silico single-fraction stereotactic ablative radiation therapy for the
treatment of thoracic and abdominal oligometastatic disease with online adaptive magnetic resonance guidance.
Adv Radiat Oncol, 6 (3) (2021), Article 100652, 10.1016/j.adro.2021.100652
66. Chuong M. Stereotactic MRI-guided adaptive radiation therapy (SMART) in one fraction (SMART ONE).
Accessed March 29, 2023. https://clinicaltrials.gov/ct2/show/NCT04939246
67. S Liu, W Fu, Z Liu, et al. MRI-guided celiac plexus neurolysis for pancreatic cancer pain: Efficacy and safety. J
Magn Reson Imaging, 44 (4) (2016), pp. 923-928, 10.1002/jmri.25246
68. G Jacobson, R Fluss, A Dany-BenShushan, et al. Coeliac plexus radiosurgery for pain management in patients
with advanced cancer: Study protocol for a phase II clinical trial. BMJ Open, 12 (3) (2022), Article e050169,
10.1136/bmjopen-2021-050169
69. L Hammer, D Hausner, M Ben-Ayun, et al. Single-fraction celiac plexus radiosurgery: A preliminary proof-ofconcept phase 2 clinical trial. Int J Radiat Oncol Biol Phys, 113 (3) (2022), pp. 588-593, 10.1016/j.ijrobp.2022.02.038
70. PJ van Houdt, Y Yang, UA van der Heide. Quantitative magnetic resonance imaging for biological imageguided adaptive radiotherapy. Front Oncol, 10 (2021), Article 615643, 10.3389/fonc.2020.615643
71. MR Tomaszewski, K Latifi, E Boyer, et al. Delta radiomics analysis of magnetic resonance guided radiotherapy
imaging data can enable treatment response prediction in pancreatic cancer. Radiat Oncol, 16 (1) (2021), p. 237,
10.1186/s13014-021-01957-5
72. GD Sanders, PJ Neumann, A Basu, et al. Recommendations for conduct, methodological practices, and
reporting of cost-effectiveness analyses: Second panel on cost-effectiveness in health and medicine. JAMA, 316
(10) (2016), pp. 1093-1103, 10.1001/jama.2016.12195
73. SD Ramsey, RJ Willke, H Glick, et al. Cost-effectiveness analysis alongside clinical trials II-An ISPOR good
research practices task force report. Value Health., 18 (2) (2015), pp. 161-172, 10.1016/j.jval.2015.02.001
74. E Basch, AP Abernethy, CD Mullins, et al. Recommendations for incorporating patient-reported outcomes
into clinical comparative effectiveness research in adult oncology. J Clin Oncol, 30 (34) (2012), pp. 4249-4255,
10.1200/JCO.2012.42.5967
75. S Siva, P Ost, M Ali. The MIRAGE trial-optical illusion or the future of prostate stereotactic radiotherapy?.
JAMA Oncol, 9 (3) (2023), pp. 373-375, 10.1001/jamaoncol.2022.6334
76. TS Hong, MA Ritter, WA Tomé, et al. Intensity-modulated radiation therapy: Emerging cancer treatment
technology. Br J Cancer, 92 (10) (2005), pp. 1819-1824, 10.1038/sj.bjc.6602577
77. R Young, B Snyder. IMRT (intensity modulated radiation therapy): Progress in technology and
reimbursement. Radiol Manage, 23 (6) (2001), pp. 20-26
78. LGW Kerkmeijer, CD Fuller, HM Verkooijen, et al. The MRI-linear accelerator consortium: Evidencebased clinical introduction of an innovation in radiation oncology connecting researchers, methodology, data
collection, quality assurance, and technical development. Front Oncol, 6 (2016), p. 215, 10.3389/fonc.2016.00215
79. J Jonsson, T Nyholm, K Söderkvist. The rationale for MR-only treatment planning for external radiotherapy.
Clin Transl Radiat Oncol, 18 (2019), pp. 60-65, 10.1016/j.ctro.2019.03.005. View PDFView articleView in
80. A Gunnlaugsson, E Persson, C Gustafsson, et al. Target definition in radiotherapy of prostate cancer
using magnetic resonance imaging only workflow. Phys Imaging Radiat Oncol, 9 (2019), pp. 89-91, 10.1016/j.
phro.2019.03.004
81 J Veera, K Lim, JA Dowling, et al. Dedicated MRI simulation for cervical cancer radiation treatment planning:
Assessing the impact on clinical target volume delineation. J Med Imaging Radiat Oncol, 63 (2) (2019), pp. 236243, 10.1111/1754-9485.12831
82. T Finazzi, MA Palacios, CJA Haasbeek, et al. Stereotactic MR-guided adaptive radiation therapy for peripheral
lung tumors. Radiother Oncol, 144 (2020), pp. 46-62, 10.1016/j.radonc.2019.10.013
44